FDA Approved: SUPPRELIN LA — Supplemental Application (Endo USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for SUPPRELIN LA (histrelin acetate) from Endo USA, Inc. The action concerns the drug’s labeling/indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Precocious Puberty

Drugs mentioned

• SUPPRELIN LA (HISTRELIN ACETATE)

Snippet

SUPPL AP for SUPPRELIN LA (HISTRELIN ACETATE)